Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Baoxin Pharmaceutical is a Chinese pharmaceutical company headquartered in the Panlong High-tech Zone of Baoji, Shaanxi Province. Established in 2003, the company specializes in the development and large-scale manufacturing of chemical drugs and Traditional Chinese Medicine (TCM) preparations. Its product portfolio primarily targets common ailments such as respiratory infections, influenza, and pain, with well-known products including Compound Paracetamol and Amantadine Hydrochloride capsules. The company operates multiple GMP-certified production lines for various dosage forms, including tablets, capsules, and granules. Baoxin Pharmaceutical is recognized as a regional high-tech enterprise and focuses on the domestic Chinese healthcare market. It maintains a strong emphasis on quality control and modernized TCM production techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Baoxin Pharmaceutical.